Related Experiment Videos
Stenting and superior vena caval syndrome
P Wilkinson1, J MacMahon, L Johnston
1Belfast City Hospital, Northern Ireland.
Irish Journal of Medical Science
|April 1, 1995
Summary
Intravascular stents effectively manage Superior Vena Cava (SVC) obstruction in cancer patients, providing significant symptom relief. This minimally invasive approach offers palliative benefits for malignant SVC obstruction.
Area of Science:
- Interventional Cardiology
- Oncology
- Vascular Surgery
Background:
- Superior Vena Cava (SVC) obstruction is a serious complication, often caused by malignant tumors.
- Management traditionally involved radiation or chemotherapy, with limited options for rapid palliation.
Observation:
- Six patients (64-85 years) with malignant SVC obstruction underwent intravascular stent insertion.
- The underlying malignancies included lung cancer (5 patients) and metastatic breast carcinoma (1 patient).
Findings:
- All patients experienced partial or complete clinical response following stenting.
- Two patients had recurrent symptoms, necessitating further intervention or management.
- Stenting demonstrated effective palliation of SVC obstruction symptoms in this cohort.
Implications:
- Intravascular stenting is a viable and effective palliative treatment for malignant SVC obstruction.
- This technique offers rapid symptom relief and improves quality of life for affected patients.
- Further research into long-term outcomes and optimal stent selection is warranted.